The Recall Desk
HighFDA (Drugs)·D-0126-2026·Announced 2025-11-05

Testosterone 87.5 mg pellets recalled over potential metal particulate matter

FarmaKeio Outsourcing is recalling 529 sterile Testosterone 87.5 mg pellets from one lot over the potential presence of metal particulate matter.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Scored 3 under the risk-of-harm criterion: metal particulate in a product inserted under the skin is a hazard, and no injuries are reported.

Plain-English summary

Testosterone 87.5 MG, one sterile pellet for subcutaneous insertion, compounded by FarmaKeio Outsourcing of Southlake, Texas, is being recalled for CGMP deviations: the potential presence of metal particulate matter.

The recall covers 529 pellets from lot 3193, expiring 17 February 2026, carrying NDC 73693-0386-01. The product was distributed nationwide in the United States and in Antigua. The FDA has classified the recall as Class II.

The pellet is inserted under the skin, so foreign particulate matter would be introduced into the body. The enforcement record describes the potential contamination and reports no injuries.

Providers and patients holding lot 3193 should stop using it and contact the firm or their prescriber.

The recalled product

Product
Testosterone 87.5 MG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, Ste 100, Southlake, TX 76092. NDC 73693-0386-01
Manufacturer
FARMAKEIO OUTSOURCING LLC
Category
Drug — Hormone implant
Hazard
  • particulate-matter
  • metal-contamination
  • cgmp-deviation
  • compounded

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot 3193
  • Exp 2/17/2026

Distribution

Distributed nationwide across the United States.

Related recalls

Same category